Simplex Trading
RDHL

Simplex Trading’s Redhill Biopharma RDHL Stock Holding History

Simplex Trading’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8
Closed -$1.51K – 9935
2022
Q4 		$1K Buy
8
+6
+300% +$2.6K ﹤0.01% 8900
2022
Q3 		$1K Sell
2
-10
-83% -$8.71K ﹤0.01% 9617
2022
Q2 		$10K Buy
12
+3
+33% +$4.12K ﹤0.01% 8305
2022
Q1 		$23K Sell
9
-39
-81% -$92.5K ﹤0.01% 8098
2021
Q4 		$124K Buy
48
+21
+78% +$84K ﹤0.01% 5916
2021
Q3 		$193K Sell
27
-1
-4% -$6.78K ﹤0.01% 5650
2021
Q2 		$190K Buy
+28
New +$193K ﹤0.01% 5763
2021
Q1 		– Sell
-12
Closed -$101K – 9823
2020
Q4 		$0 Sell
12
-3
-20% -$27K ﹤0.01% 8929
2020
Q3 		$0 Sell
15
-19
-56% -$156K ﹤0.01% 8372
2020
Q2 		$224K Buy
34
+4
+13% +$27.5K ﹤0.01% 3871
2020
Q1 		$136K Buy
30
+7
+30% +$35K ﹤0.01% 4043
2019
Q4 		$141K Buy
+23
New +$147K ﹤0.01% 4129
2018
Q4 		– Hold
0
– – – 7659
2018
Q3 		– Hold
0
– – – 7221

Other funds holding RDHL

CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
MOS
MGO One Seven Beachwood, Ohio $4.98B AUM 22.72% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Simplex Trading's RDHL Position: Q1 2023 in Review

Simplex Trading sold out of Redhill Biopharma (RDHL) in Q1 2023, closing a stake of 8 shares — an estimated $1.51K sold.

Simplex Trading first reported a position in RDHL in Q4 2019 and held it in 12 quarters. The position peaked at $224K in Q2 2020. 16 funds tracked by Wall St. Rank hold RDHL as of Q1 2023.

  • Simplex Trading reported no remaining Redhill Biopharma position as of Q1 2023 after selling out during the quarter.
  • Simplex Trading sold 8 Redhill Biopharma shares in Q1 2023, an estimated $1.51K.
  • Simplex Trading first reported a position in Redhill Biopharma in Q4 2019 and held it in 12 quarters.
  • Simplex Trading's Redhill Biopharma position peaked at $224K in Q2 2020.
  • 16 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2023.

Based on Simplex Trading's 13F filing for Q1 2023, filed 27 Apr 2023.